The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization.

Michael C WallaceShaun SamuelsonTiffany KhooJacob OoiJonathan TibballsJohn FergusonDavid B PreenMatthew KnuimanGeorge GarasGerry MacQuillanLeon A AdamsGary P Jeffrey

Published in: Journal of gastroenterology and hepatology (2020)

The MAAPE score accurately identifies HCC patients in whom RE is safe and effective. This will allow for optimal patient selection for future trials of RE versus systemic therapy.

Keyphrases

newly diagnosed
end stage renal disease
ejection fraction
prognostic factors
peritoneal dialysis
case report
stem cells
genome wide
gene expression
current status
patient reported
cell therapy